These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 34858891)

  • 21. Neither inflammatory bowel disease nor immunosuppressants are associated with an increased risk of severe COVID-19: an observational Dutch cohort study.
    Gilissen LPL; Heinen SGH; Rijpma-Jacobs L; Schoon E; Schreuder RM; Wensing AM; van der Ende-van Loon MCM; Bloemen JG; Stapelbroek JM; Stronkhorst A
    Clin Exp Med; 2022 Aug; 22(3):465-476. PubMed ID: 34542781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 Does Not Lead to an Increase in Corticosteroid Prescriptions in IBD Patients: A Nationwide Cohort Study.
    Nørgård BM; Zegers FD; Nielsen J; Knudsen T; Kjeldsen J
    Inflamm Bowel Dis; 2023 Sep; 29(9):1470-1476. PubMed ID: 37067508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and Outcomes of COVID-19 Among Patients With Inflammatory Bowel Disease-A Danish Prospective Population-based Cohort Study.
    Attauabi M; Poulsen A; Theede K; Pedersen N; Larsen L; Jess T; Rosager Hansen M; Verner-Andersen MK; V Haderslev K; Berg Lødrup A; Molazahi A; Neumann A; Wase A; Seidelin JB; Burisch J
    J Crohns Colitis; 2021 Apr; 15(4):540-550. PubMed ID: 33035299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases.
    Brenner EJ; Pigneur B; Focht G; Zhang X; Ungaro RC; Colombel JF; Turner D; Kappelman MD; Ruemmele FM
    Clin Gastroenterol Hepatol; 2021 Feb; 19(2):394-396.e5. PubMed ID: 33059040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 vaccination safety and associated health care utilization among adults with inflammatory bowel disease - a population-based self-controlled case series analysis.
    Lee JJY; Bernatsky S; Benchimol EI; Kuenzig ME; Kwong JC; Li Q; Widdifield J
    BMC Gastroenterol; 2024 May; 24(1):189. PubMed ID: 38816836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory bowel disease and risk of severe COVID-19: A nationwide population-based cohort study in Sweden.
    Ludvigsson JF; Axelrad J; Halfvarson J; Khalili H; Larsson E; Lochhead P; Roelstraete B; Simon TG; Söderling J; Olén O
    United European Gastroenterol J; 2021 Mar; 9(2):177-192. PubMed ID: 33704918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence, outcomes, and impact of COVID-19 on inflammatory bowel disease: propensity matched research network analysis.
    Hadi Y; Dulai PS; Kupec J; Mohy-Ud-Din N; Jairath V; Farraye FA; Kochhar GS
    Aliment Pharmacol Ther; 2022 Jan; 55(2):191-200. PubMed ID: 34904240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of Postpartum Flare Hospitalizations in Patients with Inflammatory Bowel Disease Persists After Six Months.
    Wen T; Faye AS; Lee KE; Friedman AM; Wright JD; Lebwohl B; Colombel JF
    Dig Dis Sci; 2022 Sep; 67(9):4278-4286. PubMed ID: 33932199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease.
    Calafat M; González-Muñoza C; Fortuny M; Roig C; Calm A; Mombiela A; Cañete F; Bertoletti F; González-González L; Teller-Martín M; Gordillo J; Mañosa M; Garcia-Planella E; Domènech E
    Aging Clin Exp Res; 2021 Aug; 33(8):2355-2359. PubMed ID: 34164799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory Bowel Disease Clinical Activity is Associated with COVID-19 Severity Especially in Younger Patients.
    Ricciuto A; Lamb CA; Benchimol EI; Walker GJ; Kennedy NA; Kuenzig ME; Kaplan GG; Kappelman MD; Ungaro RC; Colombel JF; Brenner EJ; Agrawal M; Reinisch W; Griffiths AM; Sebastian S
    J Crohns Colitis; 2022 May; 16(4):591-600. PubMed ID: 34570886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the PREPARE-IBD multicentre cohort study.
    Saifuddin A; Kent AJ; Mehta SJ; Hicks LC; Gonzalez HA; Segal JP; Brookes MJ; Subramanian S; Bhala N; Conley TE; Patel KV; ; Lamb CA; Walker GJ; Kennedy NA; Sebastian S
    Aliment Pharmacol Ther; 2022 Nov; 56(10):1460-1474. PubMed ID: 36196569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group.
    Arrigo S; Alvisi P; Banzato C; Bramuzzo M; Celano R; Civitelli F; D'Arcangelo G; Dilillo A; Dipasquale V; Felici E; Fuoti M; Gatti S; Knafelz D; Lionetti P; Mario F; Marseglia A; Martelossi S; Moretti C; Norsa L; Panceri R; Renzo S; Romano C; Romeo E; Strisciuglio C; Martinelli M
    Dig Liver Dis; 2021 Mar; 53(3):283-288. PubMed ID: 33388247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disease Flares Following COVID-19 Vaccination in Patients with Inflammatory Bowel Disease.
    Yoshida Y; Fujioka S; Moriyama T; Umeno J; Kawasaki K; Fuyuno Y; Matsuno Y; Ihara Y; Torisu T; Kitazono T
    Intern Med; 2023 Dec; 62(24):3579-3584. PubMed ID: 37779068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy: Fearless and with desire.
    Ramos L; Carrillo-Palau M; Alonso-Abreu I; Reygosa C; Hernández-Alvarez N; Amaral C; Hernández A; Benítez-Zafra F; Pérez-González F; Quintana-Díaz H; Hernandez-Guerra M
    Gastroenterol Hepatol; 2023 Apr; 46(4):255-260. PubMed ID: 35609791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of SARS-CoV-2 vaccine (Vero cells) on disease activity in patients with inflammatory bowel disease in China: a multicenter study.
    Zhang M; Huang Q; Shi C; Feng Y; Duan T; Lin T; Zhu Y; Liu G; Li H; Liu Y; Jiang B
    Int J Colorectal Dis; 2023 Feb; 38(1):31. PubMed ID: 36757427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark.
    Burisch J; Jess T; Egeberg A
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2704-2712.e3. PubMed ID: 30936024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Impact of COVID-19 on Patients with IBD in a Prospective European Cohort Study.
    Amiot A; Rahier JF; Baert F; Nahon S; Hart A; Viazis N; Biancone L; Domenech E; Reenears C; Peyrin-Biroulet L; Beaugerie L; Burisch J;
    J Crohns Colitis; 2023 Jan; 17(1):37-48. PubMed ID: 35767639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expert Opinions on the Current Therapeutic Management of Inflammatory Bowel Disease during the COVID-19 Pandemic: Japan IBD COVID-19 Taskforce, Intractable Diseases, the Health and Labor Sciences Research.
    Nakase H; Matsumoto T; Matsuura M; Iijima H; Matsuoka K; Ohmiya N; Ishihara S; Hirai F; Wagatsuma K; Yokoyama Y; Hisamatsu T
    Digestion; 2021; 102(5):814-822. PubMed ID: 32892197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence.
    Esposito S; Caminiti C; Giordano R; Argentiero A; Ramundo G; Principi N
    Front Immunol; 2022; 13():933774. PubMed ID: 35812420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients with inflammatory bowel disease on immunosuppressive drugs: perspectives' on COVID-19 and health care service during the pandemic.
    Moum KM; Moum B; Opheim R
    Scand J Gastroenterol; 2021 May; 56(5):545-551. PubMed ID: 33771086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.